mesalamine and rifamycins

mesalamine has been researched along with rifamycins in 33 studies

Research

Studies (33)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	17 (51.52)	29.6817
2010's	16 (48.48)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Marteau, P; Seksik, P	1
Brandimarte, G; Daffinà, R; Tursi, A	1
Simpson, J; Spiller, R	4
Brandimarte, G; Tursi, A	1
Tursi, A	2
Aragona, G; Cavallaro, LG; Cavestro, GM; Comparato, G; Di Mario, F; Fanigliulo, L; Franzé, A; Gnocchi, A; Iori, V; Leandro, G; Maino, M; Mazzocchi, G; Moussa, AM	1
Adamek, HE; Rinas, U	1
Brandimarte, G; Elisei, W; Giorgetti, GM; Tursi, A	1
Bulajic, M; Costamagna, G; Iacopini, F; Petruzziello, L; Shah, S	1
Di Fulvio, A; Ierfone, N; Martino, G; Pontone, P; Pontone, S; Terzakis, P	1
Aragona, G; Cavallaro, LG; Cavestro, GM; Comparato, G; Di Mario, F; Fanigliulo, L; Franzé, A; Leandro, G; Nervi, G; Pilotto, A; Sianesi, M; Soliani, P	1
Aiello, F; Brandimarte, G; Elisei, W; Giorgetti, GM; Inchingolo, CD; Tursi, A	1
Colecchia, A; Festi, D	1
Papagrigoriadis, S; Tursi, A	1
Joseph, RE; Streck, P; Tursi, A	1
Annibale, B; Barbara, G; Bosetti, C; Cuomo, R; Maconi, G	1
Brandimarte, G; Elisei, W; Giorgetti, GM; Giorgio, F; Ierardi, E; Inchingolo, CD; Nenna, R; Picchio, M; Tursi, A	1
Cohen, E; Modi, R; Spiegel, BM; Strate, LL	1
D'Haens, GR; Rietdijk, ST	1
Brandimarte, G; Elisei, W; Giorgetti, GM; Inchingolo, CD; Lecca, PG; Maiorano, M; Nenna, R; Penna, A; Picchio, M; Tursi, A	1
Danese, S; Papa, A; Tursi, A	1
Annibale, B; Bellini, D; Binda, GA; Cuomo, R; Gervaz, P; Laghi, A; Nascimbeni, R; Serventi, A	1
Gupta, S	1
Bastiani, F; Camarotto, A; Campanini, A; Cavasin, F; Dal Bo, N; De Conto, U; Di Mario, F; Gardini, L; Geremia, A; Grillo, S; Landi, S; Marastoni, C; Missorini, C; Quarantelli, E; Riccò, M; Sassi, U; Scarabello, F	1
Brandimarte, G; Di Mario, F; Elisei, W; Picchio, M; Scarpignato, C; Tursi, A	1
Andreozzi, P; Cargiolli, M; Cuomo, R; Sarnelli, G; Zito, FP	1
Fan, YC; Peery, AF	1
Bianchi, M; Chiesara, F; Dezi, A; Festa, V; Koch, M; Moretti, A; Spila Alegiani, S; Traversa, G	1
Böhm, S; Kruis, W	1

Reviews

16 review(s) available for mesalamine and rifamycins

Article	Year
Colonic diverticular disease. Clinical evidence, 2003, Issue:9 Topics: Anti-Infective Agents; Dietary Fiber; Diverticulitis, Colonic; Diverticulum, Colon; Humans; Mesalamine; Rifamycins; Rifaximin	2003
Colonic diverticular disease. Clinical evidence, 2004, Issue:11 Topics: Acute Disease; Anti-Infective Agents; Dietary Fiber; Diverticulitis, Colonic; Diverticulum, Colon; Humans; Mesalamine; Rifamycins; Rifaximin	2004
Mesalazine for diverticular disease of the colon--a new role for an old drug. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:1 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis, Colonic; Drug Therapy, Combination; Humans; Mesalamine; Rifamycins; Rifaximin	2005
Colonic diverticular disease. Clinical evidence, 2004, Issue:12 Topics: Acute Disease; Anti-Infective Agents; Dietary Fiber; Diverticulitis, Colonic; Diverticulum, Colon; Humans; Mesalamine; Rifamycins; Rifaximin	2004
[Diverticulosis/diverticulitis? What are conservative therapy possibilities?]. Medizinische Klinik (Munich, Germany : 1983), 2006, Jan-15, Volume: 101, Issue:1 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Diverticulitis; Diverticulosis, Colonic; Diverticulum; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Peritonitis; Prognosis; Recurrence; Rifamycins; Rifaximin; Risk Factors; Tomography, X-Ray Computed	2006
Colonic diverticular disease. Clinical evidence, 2005, Issue:14 Topics: Acute Disease; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Dietary Fiber; Diverticulosis, Colonic; Diverticulum, Colon; Humans; Mesalamine; Rifamycins; Rifaximin	2005
Review article: uncomplicated diverticular disease of the colon. Alimentary pharmacology & therapeutics, 2006, May-15, Volume: 23, Issue:10 Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Collagen; Colon; Colonoscopy; Dietary Fiber; Dietary Supplements; Diverticulum, Colon; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Matrix Metalloproteinases; Mesalamine; Probiotics; Rifamycins; Rifaximin; Viscera	2006
Review article: the current and evolving treatment of colonic diverticular disease. Alimentary pharmacology & therapeutics, 2009, Sep-15, Volume: 30, Issue:6 Topics: Anti-Bacterial Agents; Dietary Supplements; Diverticulitis, Colonic; Gastrointestinal Agents; Humans; Mesalamine; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Risk Factors; Secondary Prevention	2009
Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease. Digestive diseases and sciences, 2011, Volume: 56, Issue:11 Topics: Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis; Gastrointestinal Agents; Humans; Mesalamine; Probiotics; Remission Induction; Rifamycins; Rifaximin	2011
Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review. Diseases of the colon and rectum, 2011, Volume: 54, Issue:10 Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Dietary Fiber; Diverticulitis, Colonic; Diverticulum, Colon; Drug Therapy, Combination; Humans; Mesalamine; Probiotics; Rifamycins; Rifaximin	2011
Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. The American journal of gastroenterology, 2012, Volume: 107, Issue:10 Topics: Abdominal Pain; Acute Disease; Age Distribution; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Colic; Colonoscopy; Constipation; Diagnosis, Differential; Diarrhea; Dietary Fiber; Diverticulitis; Diverticulitis, Colonic; Gastrointestinal Agents; Gastrointestinal Motility; Health Status; Humans; Inflammatory Bowel Diseases; Intestines; Irritable Bowel Syndrome; Mesalamine; Metagenome; Patient Education as Topic; Probiotics; Quality of Life; Rifamycins; Rifaximin; Terminology as Topic	2012
Recent developments in the treatment of inflammatory bowel disease. Journal of digestive diseases, 2013, Volume: 14, Issue:6 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Budesonide; Certolizumab Pegol; Evidence-Based Practice; Humans; Immunoglobulin Fab Fragments; Inflammatory Bowel Diseases; Mesalamine; Polyethylene Glycols; Rifamycins; Rifaximin; Ustekinumab	2013
Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:6 Topics: Anti-Bacterial Agents; Dietary Fiber; Diverticulitis, Colonic; Diverticulum; Humans; Mesalamine; Probiotics; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin	2015
Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease. Minerva gastroenterologica e dietologica, 2017, Volume: 63, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Dietary Fiber; Diverticular Diseases; Drug Therapy, Combination; Evidence-Based Medicine; Gastrointestinal Agents; Humans; Mesalamine; Meta-Analysis as Topic; Practice Guidelines as Topic; Probiotics; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Treatment Outcome	2017
Therapeutic management of acute uncomplicated diverticulitis. Minerva gastroenterologica e dietologica, 2017, Volume: 63, Issue:2 Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Colon, Sigmoid; Diverticulitis, Colonic; Elective Surgical Procedures; Evidence-Based Medicine; Gastrointestinal Agents; Humans; Mesalamine; Practice Guidelines as Topic; Prevalence; Quality of Life; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Risk Factors; Treatment Outcome; United States	2017
[Diverticulitis : Domain of conservative or drug therapy?] Der Internist, 2017, Volume: 58, Issue:7 Topics: Anti-Bacterial Agents; Conservative Treatment; Diverticulitis; Humans; Mesalamine; Probiotics; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin	2017

Trials

3 trial(s) available for mesalamine and rifamycins

Article	Year
Efficacy of mesalazine in the treatment of symptomatic diverticular disease. Digestive diseases and sciences, 2005, Volume: 50, Issue:3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Analysis of Variance; Diverticulitis, Colonic; Diverticulum, Colon; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Male; Mesalamine; Middle Aged; Probability; Prospective Studies; Rifamycins; Rifaximin; Risk Assessment; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome	2005
[Modern indications on the medical treatment of symptomatic diverticular disease]. Il Giornale di chirurgia, 2006, Volume: 27, Issue:3 Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis, Colonic; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Rifamycins; Rifaximin; Treatment Outcome	2006
Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Digestive diseases (Basel, Switzerland), 2007, Volume: 25, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Diverticulosis, Colonic; Female; Humans; Male; Mesalamine; Middle Aged; Quality of Life; Rifamycins; Rifaximin; Surveys and Questionnaires	2007

Other Studies

14 other study(ies) available for mesalamine and rifamycins

Article	Year
[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease]. Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:2 Pt 2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Colitis, Ulcerative; Crohn Disease; Double-Blind Method; Escherichia coli; Freeze Drying; Gastrointestinal Agents; Humans; Mesalamine; Placebos; Probiotics; Randomized Controlled Trials as Topic; Recurrence; Rifamycins; Rifaximin; Saccharomyces; Time Factors	2001
Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002, Volume: 34, Issue:7 Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis, Colonic; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Recurrence; Rifamycins; Rifaximin; Severity of Illness Index; Time; Treatment Outcome	2002
Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease. Medical science monitor : international medical journal of experimental and clinical research, 2004, Volume: 10, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Prospective Studies; Remission Induction; Rifamycins; Rifaximin; Time Factors; Treatment Outcome	2004
Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon. Digestive diseases and sciences, 2006, Volume: 51, Issue:3 Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Breath Tests; Case-Control Studies; Diverticulum, Colon; Female; Gastrointestinal Transit; Humans; Lactose Intolerance; Lactulose; Male; Mesalamine; Middle Aged; Prevalence; Prognosis; Prospective Studies; Reference Values; Rifamycins; Rifaximin; Risk Assessment; Severity of Illness Index; Sex Distribution; Treatment Outcome	2006
Faecal calprotectin in colonic diverticular disease: a case-control study. International journal of colorectal disease, 2009, Volume: 24, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Colonoscopy; Diverticulosis, Colonic; Feces; Female; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Leukocyte L1 Antigen Complex; Lymphocytes; Male; Mesalamine; Middle Aged; Neutrophils; Rifamycins; Rifaximin; Severity of Illness Index	2009
Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease. The American journal of gastroenterology, 2009, Volume: 104, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis; Diverticulum, Colon; Gastrointestinal Agents; Humans; Mesalamine; Rifamycins; Rifaximin	2009
Diverticular disease: what is the best long-term treatment? Nature reviews. Gastroenterology & hepatology, 2010, Volume: 7, Issue:2 Topics: Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis; Gastrointestinal Agents; Humans; Mesalamine; Rifamycins; Rifaximin	2010
Mucosal expression of basic fibroblastic growth factor, Syndecan 1 and tumor necrosis factor-alpha in diverticular disease of the colon: a case-control study. Neurogastroenterology and motility, 2012, Volume: 24, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Colitis; Colitis, Ulcerative; Colon; Diverticulitis, Colonic; Diverticulosis, Colonic; Drug Therapy, Combination; Female; Fibroblast Growth Factor 2; Humans; Inflammation; Intestinal Mucosa; Male; Mesalamine; Metronidazole; Middle Aged; Rifamycins; Rifaximin; Syndecan-1; Treatment Outcome; Tumor Necrosis Factor-alpha	2012
Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence. European review for medical and pharmacological sciences, 2013, Volume: 17, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Diverticulitis, Colonic; Female; Follow-Up Studies; Gastrointestinal Agents; Humans; Male; Mesalamine; Middle Aged; Prospective Studies; Rifamycins; Rifaximin; Secondary Prevention; Time Factors	2013
Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines. Techniques in coloproctology, 2015, Volume: 19, Issue:10 Topics: Abscess; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colectomy; Colon; Colonography, Computed Tomographic; Colonoscopy; Colorectal Surgery; Diet; Dietary Fiber; Diverticulum, Colon; Elective Surgical Procedures; Gastrointestinal Agents; Humans; Italy; Laparoscopy; Mesalamine; Multidetector Computed Tomography; Peritonitis; Probiotics; Rifamycins; Rifaximin	2015
Infectious disease: Something in the water. Nature, 2016, 05-19, Volume: 533, Issue:7603 Topics: Bacterial Toxins; Biofilms; Campylobacter; Gastroenteritis; Giardia lamblia; Humans; Irritable Bowel Syndrome; Mesalamine; Rifamycins; Rifaximin; Serotonin; T-Lymphocytes; Vaccines	2016
A Primary-Care Interventional Model on the Diverticular Disease: Searching for the Optimal Therapeutic Schedule. Journal of clinical gastroenterology, 2016, Volume: 50 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Diet Therapy; Dietary Fiber; Diverticular Diseases; Female; Humans; Male; Mesalamine; Middle Aged; Primary Health Care; Probiotics; Prospective Studies; Rifamycins; Rifaximin; Treatment Outcome	2016
Current Management of Patients With Diverticulosis and Diverticular Disease: A Survey From the 2nd International Symposium on Diverticular Disease. Journal of clinical gastroenterology, 2016, Volume: 50 Suppl 1 Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Colonoscopy; Congresses as Topic; Disease Management; Diverticular Diseases; Diverticulosis, Colonic; Europe; Gastroenterologists; General Practitioners; Humans; Mesalamine; Practice Patterns, Physicians'; Probiotics; Rifamycins; Rifaximin; Surgeons; Surveys and Questionnaires	2016
Retrospective comparison of long-term ten-day/month rifaximin or mesalazine in prevention of relapse in acute diverticulitis. European review for medical and pharmacological sciences, 2017, Volume: 21, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Diverticulitis; Female; Humans; Male; Mesalamine; Middle Aged; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome	2017